Volume | 0 |
|
|||||
Noticias | - | ||||||
Máximo del Dia | Mínimo Máximo |
||||||
Minimo del Dia |
Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
Blue Water Biotech Inc | BWV | NASDAQ | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
0.1802 | 0.1802 |
Operaciones | Volume Operado de la Acción | Volumen promedio | Rango 52 semanas |
---|---|---|---|
0 | 0 | - | 0.1776 - 1.58 |
Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
---|---|---|---|---|
- | 0 | US$ 0.1802 | USD |
Información Financiera Blue Water Biotech Inc BWV
Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
---|---|---|---|---|---|---|
3.36M | 18.66M | - | 58k | -37.41M | -2.01 | - |
Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
---|---|---|---|---|---|
- | - | - | - |
Noticias sobre Blue Water Biotech Inc BWV
Fecha | Hora | Fuente | Noticias Artículo |
---|---|---|---|
21/12/2023 | 15:56 | Edgar (US Regulatory) | Form 8-K - Current report |
19/12/2023 | 07:00 | Edgar (US Regulatory) | Form 8-K - Current report |
19/12/2023 | 06:00 | GlobeNewswire Inc. | Onconetix™ Chief Executive Officer Dr. Neil J. Campbell.. |
18/12/2023 | 07:11 | Edgar (US Regulatory) | Form 8-K - Current report |
18/12/2023 | 06:00 | GlobeNewswire Inc. | Blue Water Biotech Acquires Proteomedix as Part of.. |
17/11/2023 | 16:23 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
02/11/2023 | 06:00 | GlobeNewswire Inc. | Blue Water Biotech Signs Non-Binding Term Sheet to Acquire a.. |
01/11/2023 | 06:00 | GlobeNewswire Inc. | Blue Water Biotech Announces It Has Regained Compliance with.. |
30/10/2023 | 08:58 | Edgar (US Regulatory) | Form 8-K - Current report |
30/10/2023 | 06:00 | GlobeNewswire Inc. | Blue Water Biotech Issues Letter to Shareholders |
20/10/2023 | 16:12 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
18/10/2023 | 16:00 | Edgar (US Regulatory) | Form 8-K - Current report |
Histórico de Datos BWV
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
6 Months | 0.39 | 0.425 | 0.1776 | 0.2636702 | 407,436 | -0.2098 | -53.79% |
1 Year | 1.05 | 1.58 | 0.1776 | 1.06 | 533,317 | -0.8698 | -82.84% |
3 Years | 50.00 | 90.90 | 0.1776 | 4.36 | 1,673,075 | -49.82 | -99.64% |
5 Years | 50.00 | 90.90 | 0.1776 | 4.36 | 1,673,075 | -49.82 | -99.64% |